Evidence map›Paper›PMID 28321150›Full record

ArticleMediators of inflammation2017

Interleukin 35 Polymorphisms Are Associated with Decreased Risk of Premature Coronary Artery Disease, Metabolic Parameters, and IL-35 Levels: The Genetics of Atherosclerotic Disease (GEA) Study.

Rosalinda Posadas-Sánchez, Nonanzit Pérez-Hernández, Javier Angeles-Martínez, Fabiola López-Bautista, Teresa Villarreal-Molina, José Manuel Rodríguez-Pérez, José Manuel Fragoso, Carlos Posadas-Romero, Gilberto Vargas-Alarcón

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 53 citations in OpenAlex.

  1. Biomedicines · 2026
    Article
  2. Article
  3. Review
  4. Biology · 2025
    Article
  5. Review
  6. Cholesterol 7 alpha-hydroxylase (Biomolecules & biomedicine · 2025
    Article
  7. Article
  8. Biomedicines · 2024
    Article
  9. Associations of theBiomedicines · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Association of the rs17574Diagnostics (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Variants ofDiagnostics (Basel, Switzerland) · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Rosalinda Posadas-SánchezDepartment of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.ORCID 0000-0001-8467-3488
Nonanzit Pérez-HernándezDepartment of Molecular Biology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.ORCID 0000-0003-4786-508X
Javier Angeles-MartínezDepartment of Molecular Biology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.ORCID 0000-0001-5405-0482
Fabiola López-BautistaDepartment of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.ORCID 0000-0001-9607-6090
Teresa Villarreal-MolinaCardiovascular Genomics Laboratory, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City, Mexico.ORCID 0000-0003-4450-7690
José Manuel Rodríguez-PérezDepartment of Molecular Biology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.ORCID 0000-0002-3802-0897
José Manuel FragosoDepartment of Molecular Biology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.ORCID 0000-0003-3137-7815
Carlos Posadas-RomeroDepartment of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Gilberto Vargas-AlarcónDepartment of Molecular Biology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.ORCID 0000-0001-7916-5163
Instituto Nacional de Cardiología · MXNational Institute of Genomic Medicine · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin 35 (IL-35) is a heterodimeric cytokine involved in the development of atherosclerosis. The aim of the present study was to establish if the polymorphisms of

Indexed as

AdultAtherosclerosisCoronary Artery DiseaseFemaleGene FrequencyGenetic Predisposition to DiseaseGenotypeHaplotypesHumansInterleukinsMaleMiddle AgedPolymorphism, Single NucleotideRisk Factorsinterleukin-35, humanInterleukins

Identifiers

PMID28321150
PMCPMC5340958
OpenAlexW2589555881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.